Latest Articles

Publication Date
Insulin resistance and endometrial cancer: The connection women need to know - MSN

Insulin resistance and endometrial cancer: The connection women need to know MSN

Published: June 30, 2026, 11:57 p.m.
Endometrial cancer after premenopausal BSO: earlier, higher incidence of new cardiovascular risk factors - Vera Health

Endometrial cancer after premenopausal BSO: earlier, higher incidence of new cardiovascular risk factors Vera Health

Published: June 30, 2026, 11:45 p.m.
Insulin Resistance and Endometrial Cancer: The Connection Women Need to Know - Onlymyhealth

Insulin Resistance and Endometrial Cancer: The Connection Women Need to Know Onlymyhealth

Published: June 30, 2026, 1:17 a.m.
Analysis of Drug Clinical Trials in Obstetrics and Gynecology: A Five-Year Retrospective Study from a Public Tertiary Specialty Hospital in China.

Women remain underrepresented in clinical drug development despite their unique biological characteristics and growing disease burden. In China, this disparity is particularly concerning given the rising incidence of gynecologic conditions …

Published: June 30, 2026, midnight
Endometrial Cancer in Women Who Have Never Been Pregnant: Understanding the Risk - Onlymyhealth

Endometrial Cancer in Women Who Have Never Been Pregnant: Understanding the Risk Onlymyhealth

Published: June 29, 2026, 5:51 p.m.
Advances in noninvasive endometrial cancer detection - MSN

Advances in noninvasive endometrial cancer detection MSN

Published: June 29, 2026, 1:12 a.m.
Celebrating 1st Anniversary of Endometrial Cancer Research Foundation - Oncodaily

Celebrating 1st Anniversary of Endometrial Cancer Research Foundation Oncodaily

Published: June 27, 2026, 5:25 a.m.
A Commentary on Dual Orphan Nuclear Receptor 4A1 (NR4A1) and NR4A2 Ligands.

1,1-Bis(3'-indolyl)-1-(3,5-disubstitutedphenyl)methane (DIM-3,5) compounds in the presence or absence of a 4-hydroxylphenyl group bind both orphan nuclear receptor 4A1 (NR4A1) and NR4A2. In cancer cells, these compounds bind and inactivate pro-oncogenic …

Published: June 27, 2026, midnight
Ovarian cancer tumor immune profiles associated with intrauterine device and oral contraceptive use.

Non-hormonal intrauterine devices (IUDs) create an inflammatory uterine environment while oral contraceptives (OC) suppress ovulation and have different associations with ovarian cancer risk. We have evaluated the associations of these …

Published: June 27, 2026, midnight
Patient-derived organoids in gynaecological cancers: emerging tools for therapy and disease modelling.

Patient-derived organoids (PDOs) have emerged as physiologically relevant three-dimensional (3D) culture systems that closely mimic the molecular and histological features of the human endometrium and associated malignancies. Owing to their …

Published: June 27, 2026, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!